EXPRESSION AND DISTRIBUTION OF ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN HYPERTROPHIC VENTRICLE OF HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY

被引:67
|
作者
TAKEMURA, G
FUJIWARA, H
MUKOYAMA, M
SAITO, Y
NAKAO, K
KAWAMURA, A
ISHIDA, M
KIDA, M
UEGAITO, T
TANAKA, M
MATSUMORI, A
FUJIWARA, T
IMURA, H
KAWAI, C
机构
[1] KYOTO UNIV, FAC MED,DEPT INTERNAL MED,DIV 3,54 KAWARA CHO, SAKYO KU, KYOTO 606, JAPAN
[2] KYOTO UNIV, FAC MED, DEPT INTERNAL MED, DIV 2, KYOTO 606, JAPAN
[3] KYOTO WOMENS UNIV, KYOTO, JAPAN
关键词
VENTRICLE; HYPERTENSION; ATRIAL NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY;
D O I
10.1161/01.CIR.83.1.181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the ventricular expression of atrial natriuretic peptide (ANP) in human hypertrophic hearts, we conducted an immunohistochemical study of 130 endomyocardial biopsy specimens obtained from the right side of the ventricular septum (RVB), left ventricular free wall (LVB), or both from a total of 80 patients: 44 patients with hypertrophic cardiomyopathy (HCM), 14 with apical hypertrophic cardiomyopathy (APH), 13 with hypertensive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive hearts (HHD), and nine without hypertrophy (controls). No patients had apparent congestive heart failure. ANP was not seen in ventricular myocytes in controls but was identified in biopsy specimens of hypertrophic hearts, and its distribution was characteristic in each hypertrophic group: 15 RBV (37%) and two LVB (7%) of the HCM group, one RBV (7%) and two LVB (18%) of the APH group, and zero RVB (0%) and five LVB (46%) of the HHD group. Clinical data (including echocardiographic, hemodynamic, and angiographic data) were not directly related to ventricular ANP expression in HCM, APH, or HHD with one exception. In HHD patients, LVB specimens with ANP showed greater ventricular wall thickness than LVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens without ANP. According to histological data, however, the ANP-present RVB specimens of HCM or ANP-present LVB specimens of HHD had greater myocyte size than did the ANP-absent specimens. In addition, in HCM patients, the ANP-present RVB specimens showed more severe fibrosis and myofiber disarray than did the ANP-absent specimens. We conclude that a failing state and hemodynamic overload are not likely to be indispensable for ANP expression in human hypertrophic ventricles and that ventricular ANP expression occurs as a response to disease-specific changes: hemodynamic overload in HHD and histological changes such as myocardial fiber disarray, hypertrophy of myocytes, and fibrosis in HCM, which may reflect the characteristic distribution of intraventricular ANP.
引用
收藏
页码:181 / 190
页数:10
相关论文
共 50 条
  • [1] EXPRESSION AND LOCALIZATION OF ANGIOTENSINOGEN AND ATRIAL-NATRIURETIC-PEPTIDE IN HUMAN HEARTS
    SATOU, M
    MEGURO, M
    SAWA, H
    TOKUCHI, F
    MOCHIZUKI, N
    YASUDA, H
    NAGASHIMA, K
    [J]. JOURNAL OF ELECTRON MICROSCOPY, 1991, 40 (04): : 280 - 280
  • [2] PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE IN HYPERTROPHIC CARDIOMYOPATHY
    DERCHI, G
    BELLONE, P
    CHIARELLA, F
    RANDAZZO, M
    ZINO, V
    VECCHIO, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (18): : 1502 - 1504
  • [3] QUANTITATIVE-ANALYSIS OF MYOCARDIAL FIBROSIS IN NORMAL HEARTS, HYPERTENSIVE HEARTS, HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    FUJIWARA, H
    ONODERA, T
    WU, DJ
    HAMASHIMA, Y
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1985, 49 (08): : 799 - 799
  • [4] MYOCARDIAL FIBER DIAMETER AND REGIONAL DISTRIBUTION IN THE VENTRICULAR WALL OF NORMAL ADULT HEARTS, HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    HOSHINO, T
    FUJIWARA, H
    KAWAI, C
    HAMASHIMA, Y
    [J]. CIRCULATION, 1983, 67 (05) : 1109 - 1116
  • [5] ATRIAL-NATRIURETIC-PEPTIDE GENE-EXPRESSION WITHIN INVERTEBRATE HEARTS
    POULOS, JE
    GOWER, WR
    FRIEDL, FE
    VESELY, DL
    [J]. GENERAL AND COMPARATIVE ENDOCRINOLOGY, 1995, 100 (01) : 61 - 68
  • [6] ATRIAL-NATRIURETIC-PEPTIDE RELEASE IN CALVES WITH ARTIFICIAL HEARTS
    WESTENFELDER, C
    BARANOWSKI, RL
    KABLITZ, C
    OLSEN, DB
    BURNS, G
    JAHAN, S
    [J]. CLINICAL RESEARCH, 1986, 34 (01): : A110 - A110
  • [7] Differences in Atrial Remodeling in Hypertrophic Cardiomyopathy Compared to Hypertensive Heart Disease and Athletes' Hearts
    Servatius, Helge
    Raab, Simon
    Asatryan, Babken
    Haeberlin, Andreas
    Branca, Mattia
    de Marchi, Stefano
    Brugger, Nicolas
    Nozica, Nikolas
    Goulouti, Eleni
    Elchinova, Elena
    Lam, Anna
    Seiler, Jens
    Noti, Fabian
    Madaffari, Antonio
    Tanner, Hildegard
    Baldinger, Samuel H.
    Reichlin, Tobias
    Wilhelm, Matthias
    Roten, Laurent
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (05)
  • [8] MYOCARDIAL FIBER DIAMETER AND ITS REGIONAL DISTRIBUTION THROUGHOUT THE VENTRICULAR WALL IN HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    HOSHINO, T
    FUJIWARA, H
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1983, 47 (03): : 375 - 376
  • [9] QUANTITATIVE-ANALYSIS OF NARROWINGS OF INTRAMYOCARDIAL SMALL ARTERIES IN NORMAL HEARTS, HYPERTENSIVE HEARTS, AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    FUJIWARA, H
    ONODERA, T
    WU, DJ
    MATSUDA, M
    HAMASHIMA, Y
    KAWAI, C
    [J]. CIRCULATION, 1987, 75 (06) : 1130 - 1139
  • [10] QUANTITATIVE-ANALYSIS OF THE STENOSIS OF INTRAMYOCARDIAL SMALL ARTERIES IN NORMAL HEARTS, HYPERTENSIVE HEARTS AND HEARTS WITH HYPERTROPHIC CARDIOMYOPATHY
    TANAKA, M
    ONODERA, T
    WU, DJ
    MATSUDA, M
    FUJIWARA, H
    KAWAI, C
    [J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (08): : 712 - 712